BEIJING, June 28, 2024 /PRNewswire/ — The 25th China-ROK photography exchange exhibition was recently held in Gunsan City of the Republic of Korea (ROK), as part of the efforts to commemorate the 30th anniversary of the sister city relationship between Yantai City in east China’s Shandong Province and Gunsan.

Photo shows the scenery of Gunsan City of the Republic of Korea. (Provided by Longkou City)Photo shows the scenery of Gunsan City of the Republic of Korea. (Provided by Longkou City)

A team of 11 representatives and photographers from Yantai carried out exchanges with their peers in the ROK during a 6-day visit to Gunsan.

Photo shows the scenery of Gunsan City of the Republic of Korea. (Provided by Longkou City)Photo shows the scenery of Gunsan City of the Republic of Korea. (Provided by Longkou City)

Since the establishment of the sister city relationship in 1994, Yantai and Gunsan have maintained close exchanges in fields such as trade, culture, and arts. Photography-themed communication between the sister cities has lasted for 22 years, with photographers from Longkou, a county-level city under Yantai, traveling to Gunsan many times and taking photos of the local scenic beauty.

See the original link: https://en.imsilkroad.com/p/340840.html

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Datasea Announces Intent of its CEO to Purchase Up $3,000,000 of its Common Stock in Open Market Purchases

BEIJING, April 9, 2024 /PRNewswire/ — Datasea Inc. (Nasdaq: DTSS) ("Datasea" or…

Emirates NBD successfully executes USD 250 Million Syndicated Term Loan facility for Dar Global, Accelerating Global Growth and Expansion

DUBAI, UAE, April 16, 2026 /PRNewswire/ — Emirates NBD, a leading banking group…

Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE2016, a First-in-Class Allogeneic Anti-EGFR Cell Therapy

ACE2016 Is an Allogeneic Gamma Delta 2 (γδ2) T Cell Therapy Targeting…